Please assess the completion status of the following clinical trial:

Trial Title: Deep Versus Moderate Neuromuscular Blockade During Laparoscopic Surgery

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: CROSSOVER
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: SINGLE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Each participant must be willing and able to provide written informed consent for the study.~* Each participant must be American Society of Anesthesiologists (ASA) class I, II or III.~* Each participant must be scheduled for elective laparoscopic surgery (this includes robotic laparoscopic surgery).~* Expected surgical duration of 60 min or longer~Exclusion Criteria:~* Inability to give informed oral or written consent~* Known or suspected neuromuscular disorders impairing neuromuscular function;~* True allergies as defined as hypotension, bronchospasm, or anaphylaxis to muscle relaxants, anesthetics or opioids~* A history (patient or family) of malignant hyperthermia~* A contraindication for neostigmine administration~* Renal insufficiency, as defined by serum creatinine levels at 2.5 fold the normal level~* Body mass index \>40 kg/m\^2~* Significant respiratory disease.~* Planned postoperative mechanical ventilation

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Deep to Moderate NMB (Type: OTHER): This group will undergo deep neuromuscular blockade, defined as post tetanic count (PTC) of 1 to 2, in the beginning portion of the surgery followed by a period of moderate blockade.
- Moderate to Deep NMB (Type: OTHER): This group will undergo moderate neuromuscular blockade, defined as 1-2 twitches, in the beginning portion of the surgery followed by a period of deep blockade.

Based on this trial design, predict the completion outcome and termination type (if applicable).